expert roundtables

Initial Treatment for Older (Age >70), Nonfrail Patients With Chronic Lymphocytic Leukemia
Oncology

Initial Treatment for Older (Age >70), Nonfrail Patients With Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jennifer R. Brown, MD, PhD
Treatment Recommendations for Focal Onset Seizures With or Without Secondary Generalization
Neurology

Treatment Recommendations for Focal Onset Seizures With or Without Secondary Generalization

expert roundtables
By Brian D. Moseley, MD; James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; Selim R. Benbadis, MD
Next Steps for Single-Agent–Refractory Epilepsy
Neurology

Next Steps for Single-Agent–Refractory Epilepsy

expert roundtables
By Brian D. Moseley, MD; James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; Selim R. Benbadis, MD
Importance of Disease-Related Symptoms in Patients With Myeloproliferative Neoplasms
Oncology

Importance of Disease-Related Symptoms in Patients With Myeloproliferative Neoplasms

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Overcoming Treatment Challenges in Polycythemia Vera
Oncology

Overcoming Treatment Challenges in Polycythemia Vera

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Load More